Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels.

Retinol inhibits the growth of all-trans-retinoic acid (ATRA)-resistant human colon cancer cell lines through a retinoic acid receptor (RAR)-independent mechanism. The objectives of the current study were to determine if retinol inhibited the invasion of ATRA-resistant colon cancer cells independent...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Cancer Vol. 57; no. 1; pp. 66 - 78
Autores principales: Park EY, Wilder ET, Lane MA
Formato: Journal Article
Publicado: Taylor & Francis Ltd 2007
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105978764&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105978764
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: 2007
      vid: 57
      iid: 1
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        105978764
        2009597285
        NLM17516864
        105978764
      ppf: 66
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels.
      aug:
        au:
          Park EY
          Wilder ET
          Lane MA
      sug:
        subj:
          Antineoplastic Agents Pharmacodynamics
          Peptide Hydrolases Metabolism
          Receptors, Cell Surface Metabolism
          Tretinoin Pharmacodynamics
          Vitamin A Pharmacodynamics
          Antineoplastic Agents Antagonists and Inhibitors
          Cells
          Colonic Neoplasms Drug Therapy
          Colonic Neoplasms Metabolism
          Colonic Neoplasms
          Dose-Response Relationship, Drug
          Drug Resistance, Neoplasm
          RNA Metabolism
          Tretinoin Antagonists and Inhibitors
          Vitamin A Antagonists and Inhibitors
      ab: Retinol inhibits the growth of all-trans-retinoic acid (ATRA)-resistant human colon cancer cell lines through a retinoic acid receptor (RAR)-independent mechanism. The objectives of the current study were to determine if retinol inhibited the invasion of ATRA-resistant colon cancer cells independent of RAR and the effects of retinol on matrix metalloproteinases (MMPs). Retinol inhibited the migration and invasion of two ATRA-resistant colon cancer cell lines, HCT-116 and SW620, in a dose-dependent manner. To determine if transcription, particularly RAR-mediated transcription, or translation of new genes was required for retinol to inhibit cell invasion, cells were treated with retinol and cycloheximide, actinomycin D, or an RAR pan-antagonist. Treatment of cells with retinol and cycloheximide, actinomycin D, or an RAR pan-antagonist did not block the ability of retinol to inhibit cell invasion. In addition, retinol decreased MMP-1 mRNA levels in both cell lines, MMP-2 mRNA levels in the SW620 cell line, and MMP-7 and -9 mRNA levels in the HCT-116 cell line. Retinol also decreased the activity of MMP-2 and -9 and MMP-9 protein levels while increasing tissue inhibitor of MMP-1 media levels. In conclusion, retinol reduces the metastatic potential of ATRA-resistant colon cancer cells via a novel RAR-independent mechanism that may involve decreased MMP mRNA levels and activity.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N